Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Influenza
Interventions
DEVICE

Respirio Flu Test

The Respirio Flu Test (RFT) is a rapid test for identifying whether a patient is infected with the Influenza A or B virus. The test separates the Influenza virus from the patient's nose blow sample and utilizes the same underlying technology as a pregnancy test (lateral flow/immuno-chromatography) to deliver a positive or negative result in less than 10 minutes. The RFT is easy to use, designed with a 3 step process similar to that of the home pregnancy test. Results are presented to the patient as a combination of different coloured lines, depending on whether the patient has Influenza A or B.

Trial Locations (2)

4068

Taringa 7 Day Medical Practice, Brisbane

4157

Capalaba Medical Centre, Brisbane

All Listed Sponsors
lead

Respirio Pty Ltd

INDUSTRY

NCT01431768 - Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B | Biotech Hunter | Biotech Hunter